ATS 2018 International Conference - Mobile

Fevipiprant, a Potent Selective Antagonist of the Prostaglandin D2 Receptor 2, Modulates the Allergic Effector Unit Via Inhibition of Eosinophil Migration Towards Mast Cells [Board No. P1029]

Location: Board no. P1029

Session Type: Thematic Poster Session

Sunday

May

20

11:15 AM

1:00 PM

Speaker(s)/Author(s)

Revital Shamri

Ph.D.
The Hebrew University of Jerusalem

Gerald Dubois

PhD
Novartis

David Sandham

PhD
Novartis Institutes for Biomedical Research

Veit Johannes. Erpenbeck

MD, PhD
Novartis;Novartis Pharma AG

Francesca Levi-schaffer

PhD
The Hebrew University of Jerusalem

View Abstract

Fevipiprant, a Potent Selective Antagonist of the Prostaglandin D2 Receptor 2, Modulates the Allergic Effector Unit Via Inhibition of Eosinophil Migration Towards Mast Cells

Parent Sessions

A32 - UPDATES IN ALLERGIC DISEASE
05-20-2018 9:15 AM - 4:15 PM